Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2018, Vol. 32 ›› Issue (6): 43-47.doi: 10.6040/j.issn.1673-3770.0.2018.329

Previous Articles     Next Articles

Clinical analysis of 68 cases of multiple primary cancers of head and neck

HUANG Fang1, WEI Guifang1, HUANG Sicheng2, HUANG Xiangqin3   

  1. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350001, Fujian, China;
    3. Deptment of General Surgery, South Branchof Fujian Provincial Hosptial, Fuzhou 350005, Fujian, China
  • Published:2018-11-29

Abstract: Objective To summarize and analyze the incidence of multiple primary cancers(MPCs)of the head and neck region in patients hospitalized in the otolaryngology department. Methods Retrospective analysis of the clinical data of 68 patients with head and neck MPCs was conducted using SPSS 21.0. Results Overall, 648 cases of malignant tumors were found in 8758 patients treated in the same period. Among them, 68 cases were diagnosed with MPC with an occurrence rate of 0.78%. The annual occurrence rate of MPC during 2014-2017 was 0.72%, 0.72%, 0.77%, and 0.86%, successively, and showed an upward trend. The MPC group included 61 males and 7 females, and the proportion of males was higher than that in a single primary cancer group. There were 62 cases of double cancer, 6 of triple cancer, 35 of synchronous carcinoma, and 33 of metachronous carcinoma. Forty-four patients had a previous history of smoking/drinking, and male smokers/drinkers were significantly higher than females(χ2 = 6.40, P=0.006). Hypopharyngeal cancer accounted for the highest incidence of MPC(23.81%), followed by oral cancer(14.71%)and laryngeal cancer(9.33%). The most common primary cancer associated with oral cancer, hypopharyngeal cancer, and laryngeal cancer was esophageal cancer. There were 45 cases(66.18%)that presented the second cancer in less than 5 years after the first. Twenty-two patients had received radiation/chemotherapy, and these patients had a higher proportion of metachronous MPC(χ2 = 18.64, P<0.001). Conclusion The highest incidence of MPC in the head and neck in consecutive order is hypopharyngeal, oral, and laryngeal cancer. There is a high possibility of head and neck cancer presenting in combination with upper gastrointestinal cancers, such as esophageal cancer. It has been suggested that gastroscopy be listed as a routine examination both pre-operatively and at follow-up. Commonly, the interval between the second and first cancer was less than 5 years; hence, the first 5 years of follow-up and long-term regular follow-up should be fortified after radiotherapy for malignant tumors. MPC should be considered when devising a radiotherapy program, and special attention should be paid to the radiation protection of the surrounding tissues and organs.

Key words: Multiple primary cancer, Head and neck cancer, Onset risk

CLC Number: 

  • R739.6
[1] Billroth T. Pathology and therapeutics, in fifty lectures. 1871[J]. Clin Orthop Relat Res, 2003, 408:4-11.
[2] Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study[J]. Am Cancer, 1932, 16(8):1358-1414.
[3] Registries IAOC. International rules for multiple primary cancers[J]. Asian Pac J Cancer Prev, 2005, 6(1):104-106.
[4] Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature[J]. Am J Clin Oncol, 2003, 26(1):79-83.
[5] 朱莉菲, 薛鹏, 王理伟. 65例多原发癌的临床回顾性研究[J]. 复旦大学学报(医学版), 2010, 37(5):591-593. ZHU Lifei, XUE Peng, WANG Liwei. Retrospective investigation of 65 cases with multiple primary cancers[J]. Fudan Univ J Med Sci, 2010, 37(5):591-593.
[6] FU J, HUANG Z, LIN Y, et al. Clinical analysis of 39 cases of multiple primary colorectal carcinoma[J]. J Southern Med Univ, 2013, 33(4):578-581.
[7] Jiao F, Yao LJ, Zhou J, et al. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients[J]. Asian Pac J Cancer Prev, 2014, 15(1):331-334.
[8] Utada M, Ohno Y, Hori M, et al. Incidence of multiple primary cancers and interval between first and second primary cancers[J]. Cancer Sci, 2014, 105(7):890-896.
[9] 田慎之, 陈福进, 曾宗渊, 等. 喉鳞状细胞癌多原发癌81例临床报道[J]. 中华耳鼻咽喉头颈外科杂志, 2006, 41(10):767-772. TIAN Shenzhi, CHEN Fujin, ZENG Zongyuan, et al. Clinical report of 81 cases of multiple primary cancers in laryngeal carcinoma[J]. Chin J Otorhinolaryngol Head Neck Surg, 2006, 41(10):767-772.
[10] 李麦冬, 胡长路. 多原发癌176例临床分析[J]. 安徽医药, 2017, 21(12):2222-2224. LI Maidong, HU Changlu. A clinical analysis of 176 cases with multiple primary malignant tumor[J]. Anhui Med Pharmaceut J, 2017, 21(12):2222-2224.
[11] Tabuchi T, Ito Y, Ioka A, et al. Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study[J]. Ann Oncol, 2013, 24(10):2699-2704.
[12] Garces YI, Schroeder DR, Nirelli LM, et al. Second primary tumors following tobacco dependence treatments among head and neck cancer patients[J]. A J Clin Oncol, 2007, 30(5):531-539.
[13] 伍国号, 陈福进, 曾宗渊,等. 放射诱发的第二原发性恶性肿瘤的临床治疗[J]. 中华肿瘤杂志, 2003, 25(3):275-277. WU Guohao, CHEN Fujin, ZENG Zongyuan, et al. Treatment of second primary malignant tumor induced by radiotherapy[J]. Chin J Oncol, 2003, 25(3):275-277.
[14] Chuang SC, Hashibe M, Yu GP, et al. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers[J]. Cancer Lett, 2006, 238(1):42-52.
[15] Patil VM, Kapoor R, Chakraborty S, et al. Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy[J]. J Cancer Res Ther, 2010, 6(4):442-447.
[16] Diallo I, Haddy N, Adjadj E, et al. Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer[J]. Int J Radiat Oncol Biol Phys, 2009, 74(3):876-883.
[17] 黄方. 头颈部放射线损伤25例临床分析[J]. 山东医大基础医学院学报, 2002, 16(2):80-84. HUANG Fang. Radiative damages of head and neck cancer in 25 cases[J]. J Preclin Med Coll of Shandong Med Univ, 2002, 16(2):80-84.
[18] Morton LM, Swerdlow AJ, Schaapveld M, et al. Current knowledge and future research directions in treatment-related second primary malignancies[J]. EJC Suppl, 2014, 12(1):5-17.
[19] Yamamoto E, Shibuya H, Yoshimura R, et al. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma[J]. Cancer, 2002, 94(7):2007-2014.
[20] Lee KD, Lu CH, Chen PT, et al. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period[J]. BMC Cancer, 2009, 9(1):373.
[21] Chuang SC, Hashibe M, Scelo G, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(6):1543-1549.
[22] Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin[J]. Cancer, 1953, 6(5):963-968.
[23] Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature[J]. Am J Clin Oncol, 2003, 26(1):79-83.
[24] Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study[J]. BMC Cancer, 2011, 11(1):83.
[25] Lee DH, Roh JL, Baek S, et al. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma[J]. Otolaryngol Head Neck Surg, 2013, 149(4):579-586.
[26] 孙俊杰, 李双庆. 多原发癌病因及发病机制的探索[J]. 中国全科医学, 2017, 20(9):1136-1141. SUN Junjie, LI Shuangqing. Exploration of etiology and pathogenesis of multiple primary malignant neoplasms[J]. Chin Gen Pract, 2017, 20(9):1136-1141.
[27] Albright JT, Karpati R, Topham AK, et al. Second malignant neoplasms in patients under 40 years of age with laryngeal cancer[J]. Laryngoscope, 2001, 111(4 Pt 1):563-567.
[28] Chuang SC, Scelo G, Lee YC, et al. Risk of second primary cancer among patients with lung cancer for men and women: A pooled analysis of 13 cancer registries[J]. Inter J Cancer, 2008, 123(10):2390.
[29] Boute P, Page C, Biet A, et al. Epidemiology, prognosis and treatment of simultaneous squamous cell carcinomas of the oral cavity and hypopharynx[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2014, 131(5):283-287.
[30] Ikeda Y, Saku M, Kawanaka H, et al. Features of second primary cancer in patients with gastric cancer[J]. Oncology, 2003, 65(2):113-117.
[31] Powell S, Tarchand G, Rector T, et al. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs(VA)tumor registry[J]. Cancer Causes Control, 2013, 24(8):1565-1573.
[32] Lopez-Oliva CL, Yun JY, Kim HS, et al. Extremity soft tissue sarcoma with multiple primary malignancies-Characteristics and outcome[J]. Eur J Surg Oncol, 2016, 42(4):567-573.
[1] SONG Xicheng. Application value of enhanced recovery after surgery in head and neck cancer surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(5): 1-4.
[2] ZHOU Juan, ZHENG Jiafa. Research progress of miRNA in head and neck cancers [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 79-82.
[3] HAN Shuang, YU Dan, WEN Lianji. Application of narrow band imaging in head and neck malignant neoplasm [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(3): 86-89.
[4] JIA Chuan-liang1,2, ZHANG Li-jing2,3, SONG Xi-cheng2. MGMT gene associated with head and neck cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 80-85.
[5] QU Chen-hui1, SHOU Jian-wei1, GUO Yan1, WANG Li-jie2, YU Xiao-xu3. Clinical practice in peri-operative care of head-neck tumor in ultrasound-guided fine needle aspiration cytology [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(2): 32-34.
[6] AN Zeng-xi, LI Xiao-yong, HOU Xiao-feng, JU Ye. 32 cases of facial and neck skin defect [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(2): 69-70.
[7] HUANG Fang,ZHU Cong-yue . Expression and significance of p21, p73 and PTEN in multiple primary cancers of the head and neck [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(5): 388-392 .
[8] ZHU Cong-yue,HuangFang . Combined expression of p21, p73 and PTEN in diagnosis of multiple primary cancers of head and neck [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(4): 352-354 .
Full text



No Suggested Reading articles found!